Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06162728
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2023-11-21
Brief Title:
Dose Escalation Trial Of Safety PharmacokineticPharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria CSU
Sponsor:
Jasper Therapeutics Inc
Organization:
Jasper Therapeutics Inc
Organization Data
Organization:
Jasper Therapeutics Inc
Class:
INDUSTRY
Study ID:
JSP-CP-011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jasper Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None